Register here to subscribe to our FREE Digital Magazine and E-Newsletter. You will get unrestricted access to all news, analysis and peer-reviewed content on our website. A print subscription is also available for €180 per annum.
Register for FREE and get unrestricted access to all news, analysis and peer-reviewed content, and create your own tailored alerts.
Novartis announced that the US Food and Drug Administration (FDA) has approved Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for…
SkinCeuticals unveils Glycolic 10 Renew Overnight – the latest addition to the Correct portfolio. This innovative product works at a…
Sun Pharma has announced late-breaking data from two pivotal Phase-3 clinical trials (reSURFACE 1 and 2) achieving the primary endpoint…
PRIME previews the 7th International Congress in Aesthetic Dermatology (ICAD 2016), taking place in Bangkok, Thailand, on 24–26 November 2016….
Acquisition adds global rights to novel NDS™ platform topical delivery technology and ANT-1207, investigational botulinum toxin type A product
Imran Majid and Gousia Sheikh review the use of microneedling for the treatment of acne scars and a growing number of new applications, such as transdermal drug delivery and hair restoration
The number of skin and soft tissue infections (SSTI) has skyrocketed owing to the spread of meticillin-resistant Staphylococcus aureus (MRSA)….
LightSheer® INFINITY™ is one of the most advanced solutions for laser hair removal and treats the broadest range of skin types
Dr Matteo Tretti Clementoni discusses his experience using lasers for the rejuvenation of the skin, and particularly the ResurFX device from Lumenis
M22™ is a modular multi-application platform for the treatment of over 30 skin conditions and hair removal. Used by physicians around…
